Posts Tagged: Diamond v. Chakrabarty
The Future of Patents on Genetically Modified Organisms in India
Earlier this year, the Supreme Court of India set aside an order of the division bench of the Delhi High Court that revoked a patent granted on …
New Study Shows Bayh-Dole is Working as Intended—and the Critics Howl
Just as the drug pricing debate on Capitol Hill is heating up, an important new study, "The Bayh-Dole Act's Vital Importance to the U.S. Life-Sciences Innovation …
At Age 46, it’s Time to Retire Benson
contrary to popular notion, U.S. Patent No. 4,344,142 to James Diehr was not the first attempt to patent the idea of performing a real-time simulation of the …
Want a greater ROI for taxpayers? Restore the patent system, protect Bayh-Dole and cut the red tape strangling federal labs
Three events boosted our economic turnaround in the 1980's: the passage of Bayh-Dole, which injected the incentives of patent ownership into the federal R&D system; the …
Want to Revive the Economy? Restore the Patent System!
The old arguments that patents inhibit innovation, and non-exclusivity with compulsory licensing leads to a brave new world are now in vogue. We've stood at this fork …
Sections 101 and 112: Eligibility, Patentability, or Somewhere in Between?
Sections 101 and 112 provide their own separate limitations to the scope of patent protection in ways that are sometimes complimentary and sometimes contradictory... Inventors are motivated to maximize …
Why Removing Section 101 Won’t be Enough
Removing section 101 would remove the language granting patents only to processes, machines, manufactures, compositions of matter, or new and useful improvements thereof. These categories however have only …
3D Printed Human Organs and the Debate on Applicable Patent Law
3D printed human organs are coming increasingly close to being a reality according to several reports. In addition to potentially saving thousands of lives every year, this …
The Broken Patent-Eligibility Test of Alice and Mayo: Why We Urgently Need to Return to Principles of Diehr and Chakrabarty*
Our Judicial Mount Olympus pays, at best, lip-service to Chakrabarty’s observation that, in enacting 35 U.S.C. § 101 in 1952, Congress chose the statutory classes (in Chakrabarty, referring …
Patent Eligibility in Unsettled Times
Today, after several years of substantial turmoil, patent eligibility in a variety of economically significant technologies is extremely uncertain, including software, natural products, medical diagnostics and personalized …
Business Methods (and Software) are Still Patentable!
For at least the past 15 years, the legal, technical and academic communities have been debating the patentability of business methods and software. Despite much negative press ink, …
Chakrabarty Controls on Isolated DNA Sequences, not Mayo*
Unfortunately this unspecific remand by the Supreme Court in AMP vacates as well the two-to-one ruling by this same Federal Circuit panel (Judges Lourie and Moore in …
Is Your Patent Portfolio Safe from the Supreme Court?
The Prometheus decision shows that you can never know for sure what the outcome will be once you arrive at the Supreme Court. We also know that …
Myriad: Isolated DNA claims from “ball bats in trees,” and “kidneys” to “magic microscopes.”
The basic argument in Myriad is whether DNA that is isolated from the chromosomes is statutory subject matter, or whether it is a product of nature. The …
Why Bilski Re-Affirms the Patent-Eligibility of Software
Even a very conservative reading of the opinions indicates that the Justices intended to leave the status of software as patent-eligible subject matter unchanged, and for further …
